Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 61 for “"Solid dispersions"”.

  1. Dissolution Behavior of Amorphous Solid Dispersions

    … enhancement techniques, such as amorphous solid dispersions (ASDs), can be used in oral dosage forms to increase the apparent solubility of the drug in the gastrointestinal tract thus increasing the bioavailability of the drug. However, the drug solution generated from the dissolution of an …

    purdue-thes Repository record for Dissolution Behavior of Amorphous Solid Dispersions (opens in a new tab)

  2. Solid dispersions: formulation, characterisation, permeability and genomic evaluation

    … reduced bioavailability. Formulation of solid dispersion of the drug has attracted considerable interest as a means of improving dissolution process of a range of poorly water soluble drugs. This current study investigates the formulation of solid dispersion for a range of poorly water …

    aston Repository record for Solid dispersions: formulation, characterisation, permeability and genomic evaluation (opens in a new tab)

  3. Evaluation and enhancement of physical stability of amorphous solid dispersions

    … and gastrointestinal permeation.[8] Amorphous solid dispersions have been widely investigated to increase the gastrointestinal permeability, and the roles played by polymers and other excipients were also studied.[9],[10] However, even after 40 years of active research there have not been many …

    mississippi Repository record for Evaluation and enhancement of physical stability of amorphous solid dispersions (opens in a new tab)

  4. Physicochemical characterization of solid dispersions prepared using hot-melt extrusion technology

    … the feasibility of HME to manufacture solid dispersions of poorly soluble drugs, bicalutamide (BL) and celecoxib (CX), and to characterize the physicochemical properties of the prepared melt extrudates by different analytical techniques. Hot melt extruded solid dispersions of BL were …

    qu-belfast Repository record for Physicochemical characterization of solid dispersions prepared using hot-melt extrusion technology (opens in a new tab)

  5. Nuclear Magnetic Resonance for the Characterisation of Hot-Melt Extruded Pharmaceutical Amorphous Solid Dispersions

    … The formulation of drug/polymer amorphous solid dispersions (ASDs) is one of the most successful strategies for improving the oral bioavailability of poorly soluble APIs. Hot-melt extrusion (HME) is one method for preparing ASDs that is growing in importance in the pharmaceutical industry. …

    cambridge Repository record for Nuclear Magnetic Resonance for the Characterisation of Hot-Melt Extruded Pharmaceutical Amorphous Solid Dispersions (opens in a new tab)

  6. Cellulose-based amorphous solid dispersions enhance rifapentine delivery characteristics and dissolution kinetics in vitro

    … rifapentine into pH-responsive amorphous solid dispersions with cellulose derivatives including: hydroxypropylmethylcellulose acetate succinate (HPMCAS), cellulose acetate suberate (CASub), and 5-carboxypentyl hydroxypropyl cellulose (CHC). Most amorphous solid dispersions reduced …

    vt Repository record for Cellulose-based amorphous solid dispersions enhance rifapentine delivery characteristics and dissolution kinetics in vitro (opens in a new tab)

  7. Assessment of nanocomposites vs. amorphous solid dispersions for dissolution enhancement of bcs class ii drugs

    … formulations (nanocomposites) and amorphous solid dispersions, shortly ASDs, are two major pharmaceutical formulation platforms used for the bioavailability enhancement of poorly water-soluble drugs. While they both have several advantages-disadvantages, a scientific comparative assessment of …

    njit Repository record for Assessment of nanocomposites vs. amorphous solid dispersions for dissolution enhancement of bcs class ii drugs (opens in a new tab)

  8. Solid Dispersions in Medium-Insoluble Hydrogels for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs

    … poorly water-soluble drugs into Amorphous Solid Dispersions (ASDs) based on medium-insoluble hydrogels is an emerging approach showing promise for tackling solubility related oral bioavailability problems. However, critical parameters important to the design of these ASDs have not been …

    toronto-retro Repository record for Solid Dispersions in Medium-Insoluble Hydrogels for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs (opens in a new tab)

  9. DEVELOPMENT OF SUPERSATURATED MATRIX SYSTEMS FOR POORLY WATER-SOLUBLE COMPOUNDS BASED ON SPRAY-DRIED SOLID DISPERSIONS

    … was to design, develop and evaluate an amorphous solid dispersion (ASD)-loaded controlled release (CR) matrix system for poorly water-soluble drug in order to enhance its solubility and dissolution rate while maintaining the stability of the supersaturated state during and after dissolution. Two …

    temple Repository record for DEVELOPMENT OF SUPERSATURATED MATRIX SYSTEMS FOR POORLY WATER-SOLUBLE COMPOUNDS BASED ON SPRAY-DRIED SOLID DISPERSIONS (opens in a new tab)

  10. The effect of additives on the molecular mobility, physical stability and dissolution of amorphous solid dispersions

    … an accelerated testing method for predicting the solid-state physical stability of drugs in amorphous solid dispersions (ASD), (ii) gain a mechanistic understanding of the stabilization in the amorphous state brought about by small molecule excipients, and (iii) investigate the relationship …

    umn Repository record for The effect of additives on the molecular mobility, physical stability and dissolution of amorphous solid dispersions (opens in a new tab)

  11. Development of Methods to Predict and Enhance the Physical Stability of Hot Melt Extruded Solid Dispersions

    The application of amorphous solid dispersions is one of the most widely used formulation strategies for the enhancement of in-vitro and in-vivo performance of poorly water-soluble drugs. However, because of their meta-stable nature, the physical stability of amorphous solid dispersions has been …

    east-anglia Repository record for Development of Methods to Predict and Enhance the Physical Stability of Hot Melt Extruded Solid Dispersions (opens in a new tab)

  12. Drug-Polymer and Drug-Lipid Miscibility for the Development of Amorphous Solid Dispersions and Solid Lipid Nanoparticles

    … treatment of prostatic carcinoma. FLT amorphous solid dispersions (SDs) and solid lipid nanoparticles (SLNs) were prepared to overcome limited solubility. Investigation of drug-polymer and drug-lipid miscibility was carried out to enhance drug performance by assessing solubility and particle …

    creighton Repository record for Drug-Polymer and Drug-Lipid Miscibility for the Development of Amorphous Solid Dispersions and Solid Lipid Nanoparticles (opens in a new tab)

  13. A Raman Spectroscopic Study of Solid Dispersions and Co-crystals During the Pharmaceutical Hot melt Extrusion Process

    … as a PAT for production of pharmaceutical solid dispersions and co-crystals. Solid dispersions (SDs) of the anti-convulsant Carbamazepine (CBZ) with two pharmaceutical grade polymers have been produced using HME at a range of drug loadings and their amorphous nature confirmed using a …

    bradford Repository record for A Raman Spectroscopic Study of Solid Dispersions and Co-crystals During the Pharmaceutical Hot melt Extrusion Process (opens in a new tab)

  14. The development of PVP-based solid dispersions using hot melt extrusion for the preparation of immediate release formulations

    … formulation design. In this respect, research on solid dispersion of hydrophilic carrier has commenced a decade ago to resolve the problem of poorly soluble drug. However, the availability of solid dispersion is commercially limited due to the concerns of its physical instability, unpredictability …

    east-anglia Repository record for The development of PVP-based solid dispersions using hot melt extrusion for the preparation of immediate release formulations (opens in a new tab)

  15. Investigating Crystallization Tendency, Miscibility and Molecular interactions of drug-polymer systems for the development of amorphous solid dispersions

    … the performance of prepared or reported SDs (solid dispersions). Crystallization tendencies of five different drugs [i.e. Curcumin (CUR), indomethacin (IND), flutaminde (FLU), dipyridamole (DIP), griseofulvin (GRI)] in absence and presence of four different polymers [i.e. polyethylene glycol …

    creighton Repository record for Investigating Crystallization Tendency, Miscibility and Molecular interactions of drug-polymer systems for the development of amorphous solid dispersions (opens in a new tab)

  16. The Influence of PVAP on the Stability of Amorphous Solid Dispersions of Itraconazole Produced using Hot Melt Extrusion Technology

    … (ITZ) in neutral pH aqueous media and in the solid-state during storage over time. Polyvinyl pyrrolidone vinyl acetate (PVPVA) was incorporated into PVAP as a carrier matrix with the aim of lowering the melt viscosity and increasing the plasticity of PVAP while maintaining its high glass …

    temple Repository record for The Influence of PVAP on the Stability of Amorphous Solid Dispersions of Itraconazole Produced using Hot Melt Extrusion Technology (opens in a new tab)

  17. Development of Amorphous Ternary Solid Dispersions of a Novel Anti-Tubercular Indole-2-Carboxamide Derivative with Curcumin/Clofazimine for Tuberculosis Treatment

    … ternary (drug-drug-hydrophilic polymer) solid dispersions to simultaneously enhance the aqueous solubility of incorporated poorly soluble drugs. A highly potent novel anti-tubercular drug (i.e., Indole-2-carboxamide derivative (North 2)) was combined with an antioxidant (i.e., curcumin) …

    creighton Repository record for Development of Amorphous Ternary Solid Dispersions of a Novel Anti-Tubercular Indole-2-Carboxamide Derivative with Curcumin/Clofazimine for Tuberculosis Treatment (opens in a new tab)

Page 1 of 4